α-Hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis
- 10 March 2009
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (10), 4030-4035
- https://doi.org/10.1073/pnas.0807044106
Abstract
Escherichia coli is the dominant facultative bacterium in the normal intestinal flora. E. coli is, however, also responsible for the majority of serious extraintestinal infections. There are distinct serotypical differences between facultative and invasive E. coli strains. Invasive strains frequently produce virulence factors such as alpha-hemolysin (HlyA), which causes hemolysis by forming pores in the erythrocyte membrane. The present study reveals that this pore formation triggers purinergic receptor activation to mediate the full hemolytic action. Non-selective ATP-receptor (P2) antagonists (PPADS, suramin) and ATP scavengers (apyrase, hexokinase) concentration dependently inhibited HlyA-induced lysis of equine, murine, and human erythrocytes. The pattern of responsiveness to more selective P2-antagonists implies that both P2X(1) and P2X(7) receptors are involved in HlyA-induced hemolysis in all three species. In addition, our results also propose a role for the pore protein pannexin1 in HlyA-induced hemolysis, as non-selective inhibitors of this channel significantly reduced hemolysis in the three species. In conclusion, activation of P2X receptors and possibly also pannexins augment hemolysis induced by the bacterial toxin, HlyA. These findings potentially have clinical perspectives as P2 antagonists may ameliorate symptoms during sepsis with hemolytic bacteria.Keywords
This publication has 62 references indexed in Scilit:
- A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATPAmerican Journal of Physiology-Cell Physiology, 2009
- Pharmacological Characterization of Pannexin-1 Currents Expressed in Mammalian CellsJournal of Pharmacology and Experimental Therapeutics, 2008
- Ectodomain Lysines and Suramin Block of P2X1 ReceptorsPublished by Elsevier BV ,2008
- The P2X7 Receptor Channel Pore Dilates under Physiological Ion ConditionsThe Journal of general physiology, 2008
- Probenecid, a gout remedy, inhibits pannexin 1 channelsAmerican Journal of Physiology-Cell Physiology, 2008
- Patch–clamp coordinated spectroscopy shows P2X 2 receptor permeability dynamics require cytosolic domain rearrangements but not Panx-1 channelsProceedings of the National Academy of Sciences of the United States of America, 2008
- Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acidsBritish Journal of Pharmacology, 2007
- Pannexin1 is part of the pore forming unit of the P2X7 receptor death complexFEBS Letters, 2007
- Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptorThe EMBO Journal, 2006
- Pannexin 1 in erythrocytes: Function without a gapProceedings of the National Academy of Sciences, 2006